Syndicate Bio is set to revolutionize cancer care in Nigeria with cutting-edge cancer genetic testing services tailored for physicians and patients.
We use Next Generation Sequencing technology to offer a more detailed and comprehensive analysis of the genetic profile of various cancers. This means doctors can offer treatments that are exactly right for the specific type of cancer someone has, helping patients in a way that was not possible before.
This test identifies the genetic mutations in tumors across a wide range of organs like lungs, breast, colon, pancreas, prostate, skin, brain, ovary, stomach, liver, bladder, thyroid, and kidney.
This test aims to detect mutations that might increase a person's risk of developing inherited cancers such as breast and ovarian cancer, thyroid cancer, and colorectal cancer.
The BRCA gene test looks for mutations in the BRCA1 and BRCA2 genes. Changes in these genes significantly increase the risk of developing breast cancer (male and female), ovarian cancer, prostate cancer, and pancreatic cancer.
This test identifies mutations linked to blood cancers, including various leukemia types (Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Chronic Myeloid Leukemia (CML), lymphomas (Non-Hodgkin and Hodgkin), and myeloma, as well as conditions like Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPNs).
This cutting-edge and non-invasive test is designed to detect cancerous mutations directly from circulating tumor DNA in the bloodstream. It offers a comprehensive genomic profile, helping to guide personalized treatment options for a variety of cancers without the need for traditional tissue biopsies.
If you're interested in our genetic testing services or wish to receive updates, please fill out the form below
